Search

everythinglearnresearchcommunity

for

Search:↓

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Testosterone increases heart and blood pressure issues in rats with endotoxemia, and stopping testosterone production can reduce these problems.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Castration and finasteride lower urinary oxalate in male rats, potentially treating urolithiasis.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Finasteride does not prevent bladder cancer.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Some supplements and hormones can increase hair loss by raising DHT levels.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

The combination of azelaic acid, minoxidil, and caffeine significantly increased the survival of skin flaps by affecting certain body channels and nitric oxide levels.

Dutasteride helps reduce male pattern hair loss, but may cause side effects like altered libido and erectile dysfunction.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.